Physician
Desert Valley Medical Group, INC.
Desert Valley Medical Group, INC. was paid $755K by Medicaid between May 2018 and Oct 2021, across 55 billing codes. Its largest line is S9083, Global fee urgent care centers — 77% of everything it billed.
33Billing provider infoDESERT VALLEY MEDICAL GROUP, INC.
APPLE VALLEY, CA 92308
APPLE VALLEY, CA 92308
33aNPI1295031052assigned 01/26/2011
33bProvider typeFamily Medicine Physician
28Total paid$755K
24GClaims33,413
24DCodes billed55
24AFirst – last monthMay 2018 – Oct 2021
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#203 of 2,511
Median peer was paid$13K
This provider vs. median59×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 401 | $12K | |
| 2019 | 11,101 | $323K | |
| 2020 | 8,138 | $217K | |
| 2021 | 13,773 | $203K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 77% | 10,589 | 9,888 | $581K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.1% | 2,860 | 2,717 | $31K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.0% | 346 | 342 | $22K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.7% | 647 | 643 | $21K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.7% | 1,930 | 1,733 | $20K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.9% | 506 | 495 | $15K |
| 99223 | Prolong inpt eval add15 m | 1.8% | 243 | 239 | $14K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 3,148 | 2,909 | $13K |
| 93000 | <1% | 294 | 292 | $6K | |
| 99381 | <1% | 190 | 190 | $5K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | <1% | 94 | 93 | $4K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | <1% | 250 | 104 | $4K |
43 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,440 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 117 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 92 | $3K |
| 92551 | <1% | 211 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 380 | $1K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 60 | $1K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 310 | $993.12 |
| 99383 | <1% | 199 | $651.36 | |
| 99384 | <1% | 117 | $455.84 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 15 | $362.10 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 678 | $285.12 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 708 | $259.14 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 45 | $187.10 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 144 | $162.84 |
| 88720 | <1% | 32 | $131.10 | |
| 99442 | <1% | 34 | $121.98 | |
| 99382 | <1% | 87 | $93.32 | |
| 99188 | <1% | 511 | $89.10 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 729 | $78.74 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 25 | $72.47 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 234 | $43.41 |
| 96127 | <1% | 62 | $23.80 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 460 | $10.94 |
| 94760 | 0% | 2,290 | $0.00 | |
| 3080F | 0% | 50 | $0.00 | |
| 3079F | 0% | 151 | $0.00 | |
| 3075F | 0% | 88 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 45 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 16 | $0.00 |
| 3074F | 0% | 282 | $0.00 | |
| 99070 | 0% | 21 | $0.00 | |
| A6222 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 12 | $0.00 |
| 1111F | 0% | 19 | $0.00 | |
| 81002 | 0% | 1,516 | $0.00 | |
| 3078F | 0% | 310 | $0.00 | |
| 81025 | 0% | 154 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 15 | $0.00 |
| G9920 | Screening performed and negative | 0% | 329 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 26 | $0.00 |
| 3077F | 0% | 140 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 103 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 14 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBHATIA, KAVITHA (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Desert Valley Medical Group, INC. | Victorville, CA | $15.92M |
| Desert Valley Medical Group, INC. | Adelanto, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.